Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 364 entries
Sorted by: Best Match Show Resources per page
[Evaluation of the widespread use of MRI from an economic viewpoint].

Nihon rinsho. Japanese journal of clinical medicine

Furuse M.
PMID: 3820688
Nihon Rinsho. 1987 Jan;45(1):67-70.

No abstract available.

Cite
Furuse M. [Evaluation of the widespread use of MRI from an economic viewpoint]. Nihon Rinsho. 1987;45(1):67-70
Furuse, M. (1987). [Evaluation of the widespread use of MRI from an economic viewpoint]. Nihon rinsho. Japanese journal of clinical medicine, 45(1), 67-70.
Furuse, M. "[Evaluation of the widespread use of MRI from an economic viewpoint]." Nihon rinsho. Japanese journal of clinical medicine vol. 45,1 (1987): 67-70.
Furuse M. [Evaluation of the widespread use of MRI from an economic viewpoint]. Nihon Rinsho. 1987 Jan;45(1):67-70. Japanese. PMID: 3820688.
Copy Download .nbib Format: NLM
Clinical characteristics of epileptic seizures in a case of dihydropteridine reductase deficiency.

Epilepsy & behavior case reports

Furujo M, Kinoshita M, Ichiba Y, Romstad A, Shintaku H, Kubo T.
PMID: 25667865
Epilepsy Behav Case Rep. 2014 Mar 13;2:37-9. doi: 10.1016/j.ebcr.2014.01.007. eCollection 2014.

We assessed the clinical characteristics and efficacy of neurotransmitters and levetiracetam in a patient with hyperphenylalaninemia due to dihydropteridine reductase (DHPR) deficiency who developed epileptic seizures. A boy with DHPR deficiency, who had been successfully treated with tetrahydrobiopterin (BH4),...

Cite
Furujo M, Kinoshita M, Ichiba Y, et al. Clinical characteristics of epileptic seizures in a case of dihydropteridine reductase deficiency. Epilepsy Behav Case Rep. 2014;2:37-9doi: 10.1016/j.ebcr.2014.01.007.
Furujo, M., Kinoshita, M., Ichiba, Y., Romstad, A., Shintaku, H., & Kubo, T. (2014). Clinical characteristics of epileptic seizures in a case of dihydropteridine reductase deficiency. Epilepsy & behavior case reports, 237-9. https://doi.org/10.1016/j.ebcr.2014.01.007
Furujo, Mahoko, et al. "Clinical characteristics of epileptic seizures in a case of dihydropteridine reductase deficiency." Epilepsy & behavior case reports vol. 2 (2014): 37-9. doi: https://doi.org/10.1016/j.ebcr.2014.01.007
Furujo M, Kinoshita M, Ichiba Y, Romstad A, Shintaku H, Kubo T. Clinical characteristics of epileptic seizures in a case of dihydropteridine reductase deficiency. Epilepsy Behav Case Rep. 2014 Mar 13;2:37-9. doi: 10.1016/j.ebcr.2014.01.007. eCollection 2014. PMID: 25667865; PMCID: PMC4308063.
Copy Download .nbib Format: NLM
Severe Granulomatous Rosacea in a Boy Successfully Treated with Topical Azelaic Acid.

Indian journal of dermatology

Mitoma C, Takahara M, Furue M.
PMID: 26120187
Indian J Dermatol. 2015 May-Jun;60(3):323. doi: 10.4103/0019-5154.156460.

No abstract available.

Cite
Mitoma C, Takahara M, Furue M. Severe Granulomatous Rosacea in a Boy Successfully Treated with Topical Azelaic Acid. Indian J Dermatol. 2015;60(3):323doi: 10.4103/0019-5154.156460.
Mitoma, C., Takahara, M., & Furue, M. (2015). Severe Granulomatous Rosacea in a Boy Successfully Treated with Topical Azelaic Acid. Indian journal of dermatology, 60(3), 323. https://doi.org/10.4103/0019-5154.156460
Mitoma, Chikage, et al. "Severe Granulomatous Rosacea in a Boy Successfully Treated with Topical Azelaic Acid." Indian journal of dermatology vol. 60,3 (2015): 323. doi: https://doi.org/10.4103/0019-5154.156460
Mitoma C, Takahara M, Furue M. Severe Granulomatous Rosacea in a Boy Successfully Treated with Topical Azelaic Acid. Indian J Dermatol. 2015 May-Jun;60(3):323. doi: 10.4103/0019-5154.156460. PMID: 26120187; PMCID: PMC4458974.
Copy Download .nbib Format: NLM
Prognostic Significance of Forkhead Box M1 (FOXM1) Expression and Antitumor Effect of FOXM1 Inhibition in Angiosarcoma.

Journal of Cancer

Ito T, Kohashi K, Yamada Y, Iwasaki T, Maekawa A, Kuda M, Hoshina D, Abe R, Furue M, Oda Y.
PMID: 27162541
J Cancer. 2016 Apr 27;7(7):823-30. doi: 10.7150/jca.14461. eCollection 2016.

BACKGROUND: The prognosis of angiosarcoma is poor and a novel treatment option for the disease is desired. The aim of this study was to investigate the prognostic significance of Forkhead box M1 (FOXM1), a transcription factor that regulates cell-cycle...

Cite
Ito T, Kohashi K, Yamada Y, et al. Prognostic Significance of Forkhead Box M1 (FOXM1) Expression and Antitumor Effect of FOXM1 Inhibition in Angiosarcoma. J Cancer. 2016;7(7):823-30doi: 10.7150/jca.14461.
Ito, T., Kohashi, K., Yamada, Y., Iwasaki, T., Maekawa, A., Kuda, M., Hoshina, D., Abe, R., Furue, M., & Oda, Y. (2016). Prognostic Significance of Forkhead Box M1 (FOXM1) Expression and Antitumor Effect of FOXM1 Inhibition in Angiosarcoma. Journal of Cancer, 7(7), 823-30. https://doi.org/10.7150/jca.14461
Ito, Takamichi, et al. "Prognostic Significance of Forkhead Box M1 (FOXM1) Expression and Antitumor Effect of FOXM1 Inhibition in Angiosarcoma." Journal of Cancer vol. 7,7 (2016): 823-30. doi: https://doi.org/10.7150/jca.14461
Ito T, Kohashi K, Yamada Y, Iwasaki T, Maekawa A, Kuda M, Hoshina D, Abe R, Furue M, Oda Y. Prognostic Significance of Forkhead Box M1 (FOXM1) Expression and Antitumor Effect of FOXM1 Inhibition in Angiosarcoma. J Cancer. 2016 Apr 27;7(7):823-30. doi: 10.7150/jca.14461. eCollection 2016. PMID: 27162541; PMCID: PMC4860799.
Copy Download .nbib Format: NLM
A prospective, multicentre, single-arm clinical trial of bevacizumab for patients with surgically untreatable, symptomatic brain radiation necrosis.

Neuro-oncology practice

Furuse M, Nonoguchi N, Kuroiwa T, Miyamoto S, Arakawa Y, Shinoda J, Miwa K, Iuchi T, Tsuboi K, Houkin K, Terasaka S, Tabei Y, Nakamura H, Nagane M, Sugiyama K, Terasaki M, Abe T, Narita Y, Saito N, Mukasa A, Ogasawara K, Beppu T, Kumabe T, Nariai T, Tsuyuguchi N, Nakatani E, Kurisu S, Nakagawa Y, Miyatake SI.
PMID: 27833757
Neurooncol Pract. 2016 Dec;3(4):272-280. doi: 10.1093/nop/npv064. Epub 2016 Jan 07.

BACKGROUND: Brain radiation necrosis (BRN) can be a complication of radiotherapy for primary and secondary brain tumors, as well as head and neck tumors. Since vascular endothelial growth factor (VEGF) is also a vascular permeability factor in the brain,...

Cite
Furuse M, Nonoguchi N, Kuroiwa T, et al. A prospective, multicentre, single-arm clinical trial of bevacizumab for patients with surgically untreatable, symptomatic brain radiation necrosis. Neurooncol Pract. 2016;3(4):272-280doi: 10.1093/nop/npv064.
Furuse, M., Nonoguchi, N., Kuroiwa, T., Miyamoto, S., Arakawa, Y., Shinoda, J., Miwa, K., Iuchi, T., Tsuboi, K., Houkin, K., Terasaka, S., Tabei, Y., Nakamura, H., Nagane, M., Sugiyama, K., Terasaki, M., Abe, T., Narita, Y., Saito, N., Mukasa, A., Ogasawara, K., Beppu, T., Kumabe, T., Nariai, T., Tsuyuguchi, N., Nakatani, E., Kurisu, S., Nakagawa, Y., & Miyatake, S. I. (2016). A prospective, multicentre, single-arm clinical trial of bevacizumab for patients with surgically untreatable, symptomatic brain radiation necrosis. Neuro-oncology practice, 3(4), 272-280. https://doi.org/10.1093/nop/npv064
Furuse, Motomasa, et al. "A prospective, multicentre, single-arm clinical trial of bevacizumab for patients with surgically untreatable, symptomatic brain radiation necrosis." Neuro-oncology practice vol. 3,4 (2016): 272-280. doi: https://doi.org/10.1093/nop/npv064
Furuse M, Nonoguchi N, Kuroiwa T, Miyamoto S, Arakawa Y, Shinoda J, Miwa K, Iuchi T, Tsuboi K, Houkin K, Terasaka S, Tabei Y, Nakamura H, Nagane M, Sugiyama K, Terasaki M, Abe T, Narita Y, Saito N, Mukasa A, Ogasawara K, Beppu T, Kumabe T, Nariai T, Tsuyuguchi N, Nakatani E, Kurisu S, Nakagawa Y, Miyatake SI. A prospective, multicentre, single-arm clinical trial of bevacizumab for patients with surgically untreatable, symptomatic brain radiation necrosis. Neurooncol Pract. 2016 Dec;3(4):272-280. doi: 10.1093/nop/npv064. Epub 2016 Jan 07. PMID: 27833757; PMCID: PMC5099992.
Copy Download .nbib Format: NLM
p16.

Annals of dermatology

Uryu M, Furue M.
PMID: 28566925
Ann Dermatol. 2017 Jun;29(3):373-376. doi: 10.5021/ad.2017.29.3.373. Epub 2017 May 11.

No abstract available.

Cite
Uryu M, Furue M. p16. Ann Dermatol. 2017;29(3):373-376doi: 10.5021/ad.2017.29.3.373.
Uryu, M., & Furue, M. (2017). p16. Annals of dermatology, 29(3), 373-376. https://doi.org/10.5021/ad.2017.29.3.373
Uryu, Miki, and Furue, Masutaka. "p16." Annals of dermatology vol. 29,3 (2017): 373-376. doi: https://doi.org/10.5021/ad.2017.29.3.373
Uryu M, Furue M. p16. Ann Dermatol. 2017 Jun;29(3):373-376. doi: 10.5021/ad.2017.29.3.373. Epub 2017 May 11. PMID: 28566925; PMCID: PMC5438955.
Copy Download .nbib Format: NLM
Biological Effects of Culture Substrates on Human Pluripotent Stem Cells.

Stem cells international

Hayashi Y, Furue MK.
PMID: 27656216
Stem Cells Int. 2016;2016:5380560. doi: 10.1155/2016/5380560. Epub 2016 Aug 30.

In recent years, as human pluripotent stem cells (hPSCs) have been commonly cultured in feeder-free conditions, a number of cell culture substrates have been applied or developed. However, the functional roles of these substrates in maintaining hPSC self-renewal remain...

Cite
Hayashi Y, Furue MK. Biological Effects of Culture Substrates on Human Pluripotent Stem Cells. Stem Cells Int. 2016;2016:5380560doi: 10.1155/2016/5380560.
Hayashi, Y., & Furue, M. K. (2016). Biological Effects of Culture Substrates on Human Pluripotent Stem Cells. Stem cells international, 20165380560. https://doi.org/10.1155/2016/5380560
Hayashi, Yohei, and Furue, Miho Kusuda. "Biological Effects of Culture Substrates on Human Pluripotent Stem Cells." Stem cells international vol. 2016 (2016): 5380560. doi: https://doi.org/10.1155/2016/5380560
Hayashi Y, Furue MK. Biological Effects of Culture Substrates on Human Pluripotent Stem Cells. Stem Cells Int. 2016;2016:5380560. doi: 10.1155/2016/5380560. Epub 2016 Aug 30. PMID: 27656216; PMCID: PMC5021488.
Copy Download .nbib Format: NLM
Development of a Monitoring Method for Nonlabeled Human Pluripotent Stem Cell Growth by Time-Lapse Image Analysis.

Stem cells translational medicine

Suga M, Kii H, Niikura K, Kiyota Y, Furue MK.
PMID: 25972146
Stem Cells Transl Med. 2015 Jul;4(7):720-30. doi: 10.5966/sctm.2014-0242. Epub 2015 May 13.

UNLABELLED: : Cell growth is an important criterion for determining healthy cell conditions. When somatic cells or cancer cells are dissociated into single cells for passaging, the cell numbers can be counted at each passage, providing information on cell...

Cite
Suga M, Kii H, Niikura K, et al. Development of a Monitoring Method for Nonlabeled Human Pluripotent Stem Cell Growth by Time-Lapse Image Analysis. Stem Cells Transl Med. 2015;4(7):720-30doi: 10.5966/sctm.2014-0242.
Suga, M., Kii, H., Niikura, K., Kiyota, Y., & Furue, M. K. (2015). Development of a Monitoring Method for Nonlabeled Human Pluripotent Stem Cell Growth by Time-Lapse Image Analysis. Stem cells translational medicine, 4(7), 720-30. https://doi.org/10.5966/sctm.2014-0242
Suga, Mika, et al. "Development of a Monitoring Method for Nonlabeled Human Pluripotent Stem Cell Growth by Time-Lapse Image Analysis." Stem cells translational medicine vol. 4,7 (2015): 720-30. doi: https://doi.org/10.5966/sctm.2014-0242
Suga M, Kii H, Niikura K, Kiyota Y, Furue MK. Development of a Monitoring Method for Nonlabeled Human Pluripotent Stem Cell Growth by Time-Lapse Image Analysis. Stem Cells Transl Med. 2015 Jul;4(7):720-30. doi: 10.5966/sctm.2014-0242. Epub 2015 May 13. PMID: 25972146; PMCID: PMC4479621.
Copy Download .nbib Format: NLM
Growth phase-dependent transcription of emrKY, a homolog of multidrug efflux emrAB genes of Escherichia coli, is induced by tetracycline.

The Journal of general and applied microbiology

Tanabe H, Yamasak K, Furue M, Yamamoto K, Katoh A, Yamamoto M, Yoshioka S, Tagami H, Aiba HA, Utsumi R.
PMID: 12501312
J Gen Appl Microbiol. 1997 Oct;43(5):257-263. doi: 10.2323/jgam.43.257.

The genes emrK and emrY were found between genes dsdA and evgA at 51 min on the Escherichia coli chromosome and form an operon. EmrK and EmrY are 50.4 and 63.3% identical in amino acid sequences to EmrA and...

Cite
Tanabe H, Yamasak K, Furue M, et al. Growth phase-dependent transcription of emrKY, a homolog of multidrug efflux emrAB genes of Escherichia coli, is induced by tetracycline. J Gen Appl Microbiol. 1997;43(5):257-263doi: 10.2323/jgam.43.257.
Tanabe, H., Yamasak, K., Furue, M., Yamamoto, K., Katoh, A., Yamamoto, M., Yoshioka, S., Tagami, H., Aiba, H. A., & Utsumi, R. (1997). Growth phase-dependent transcription of emrKY, a homolog of multidrug efflux emrAB genes of Escherichia coli, is induced by tetracycline. The Journal of general and applied microbiology, 43(5), 257-263. https://doi.org/10.2323/jgam.43.257
Tanabe, Hiroyuki, et al. "Growth phase-dependent transcription of emrKY, a homolog of multidrug efflux emrAB genes of Escherichia coli, is induced by tetracycline." The Journal of general and applied microbiology vol. 43,5 (1997): 257-263. doi: https://doi.org/10.2323/jgam.43.257
Tanabe H, Yamasak K, Furue M, Yamamoto K, Katoh A, Yamamoto M, Yoshioka S, Tagami H, Aiba HA, Utsumi R. Growth phase-dependent transcription of emrKY, a homolog of multidrug efflux emrAB genes of Escherichia coli, is induced by tetracycline. J Gen Appl Microbiol. 1997 Oct;43(5):257-263. doi: 10.2323/jgam.43.257. PMID: 12501312.
Copy Download .nbib Format: NLM
Discovery of novel dyes with absorption maxima at 1.1 microm.

Journal of the American Chemical Society

Tian M, Tatsuura S, Furuki M, Sato Y, Iwasa I, Pu LS.
PMID: 12517143
J Am Chem Soc. 2003 Jan 15;125(2):348-9. doi: 10.1021/ja0209666.

During the process of developing organic molecules that match the wavelengths used in optical communications, we have discovered a new class of dyes, with absorption maxima at 1.1 mum, and clarified their molecular structures. The synthesis of this class...

Cite
Tian M, Tatsuura S, Furuki M, et al. Discovery of novel dyes with absorption maxima at 1.1 microm. J Am Chem Soc. 2003;125(2):348-9doi: 10.1021/ja0209666.
Tian, M., Tatsuura, S., Furuki, M., Sato, Y., Iwasa, I., & Pu, L. S. (2003). Discovery of novel dyes with absorption maxima at 1.1 microm. Journal of the American Chemical Society, 125(2), 348-9. https://doi.org/10.1021/ja0209666
Tian, Minquan, et al. "Discovery of novel dyes with absorption maxima at 1.1 microm." Journal of the American Chemical Society vol. 125,2 (2003): 348-9. doi: https://doi.org/10.1021/ja0209666
Tian M, Tatsuura S, Furuki M, Sato Y, Iwasa I, Pu LS. Discovery of novel dyes with absorption maxima at 1.1 microm. J Am Chem Soc. 2003 Jan 15;125(2):348-9. doi: 10.1021/ja0209666. PMID: 12517143.
Copy Download .nbib Format: NLM
Protonation studies of reduced ruthenium(II) complexes with polypyridyl ligands.

Inorganic chemistry

Anderson PA, Anderson RF, Furue M, Junk PC, Keene FR, Patterson BT, Yeomans BD.
PMID: 11232806
Inorg Chem. 2000 Jun 26;39(13):2721-8. doi: 10.1021/ic991070d.

The pKa values associated with protonation of the one-electron reduced forms of series of [L'2Ru(II)L]2+ complexes [L' = bidentate polypyridyl ligand; L = bidentate polypyridyl ligand with additional uncoordinated N atoms in the aromatic ring system: e.g., dpp =...

Cite
Anderson PA, Anderson RF, Furue M, et al. Protonation studies of reduced ruthenium(II) complexes with polypyridyl ligands. Inorg Chem. 2000;39(13):2721-8doi: 10.1021/ic991070d.
Anderson, P. A., Anderson, R. F., Furue, M., Junk, P. C., Keene, F. R., Patterson, B. T., & Yeomans, B. D. (2000). Protonation studies of reduced ruthenium(II) complexes with polypyridyl ligands. Inorganic chemistry, 39(13), 2721-8. https://doi.org/10.1021/ic991070d
Anderson, P A, et al. "Protonation studies of reduced ruthenium(II) complexes with polypyridyl ligands." Inorganic chemistry vol. 39,13 (2000): 2721-8. doi: https://doi.org/10.1021/ic991070d
Anderson PA, Anderson RF, Furue M, Junk PC, Keene FR, Patterson BT, Yeomans BD. Protonation studies of reduced ruthenium(II) complexes with polypyridyl ligands. Inorg Chem. 2000 Jun 26;39(13):2721-8. doi: 10.1021/ic991070d. PMID: 11232806.
Copy Download .nbib Format: NLM
Effect of aggregation on the excited-state electronic structure of perylene studied by transient absorption spectroscopy.

The journal of physical chemistry. A

Furube A, Murai M, Tamaki Y, Watanabe S, Katoh R.
PMID: 16706403
J Phys Chem A. 2006 May 25;110(20):6465-71. doi: 10.1021/jp060649b.

The effect of aggregation on the excited-state electronic structure of perylene was studied through transient absorption measurements of isolated molecules, excimers, monomeric crystals (beta-perylene), and dimeric crystals (alpha-perylene). Changes of electronic state were clearly identified from the changes in...

Cite
Furube A, Murai M, Tamaki Y, et al. Effect of aggregation on the excited-state electronic structure of perylene studied by transient absorption spectroscopy. J Phys Chem A. 2006;110(20):6465-71doi: 10.1021/jp060649b.
Furube, A., Murai, M., Tamaki, Y., Watanabe, S., & Katoh, R. (2006). Effect of aggregation on the excited-state electronic structure of perylene studied by transient absorption spectroscopy. The journal of physical chemistry. A, 110(20), 6465-71. https://doi.org/10.1021/jp060649b
Furube, Akihiro, et al. "Effect of aggregation on the excited-state electronic structure of perylene studied by transient absorption spectroscopy." The journal of physical chemistry. A vol. 110,20 (2006): 6465-71. doi: https://doi.org/10.1021/jp060649b
Furube A, Murai M, Tamaki Y, Watanabe S, Katoh R. Effect of aggregation on the excited-state electronic structure of perylene studied by transient absorption spectroscopy. J Phys Chem A. 2006 May 25;110(20):6465-71. doi: 10.1021/jp060649b. PMID: 16706403.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 364 entries